Cargando…

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry

Chronic hepatitis B virus (HBV) infection, affecting approximately 240 million people worldwide, is a major public health problem that elevates the risk of developing liver cirrhosis and hepatocellular carcinoma. Given that current anti-HBV drugs are limited to interferon-based regimens and nucleos(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watashi, Koichi, Urban, Stephan, Li, Wenhui, Wakita, Takaji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958888/ https://www.ncbi.nlm.nih.gov/pubmed/24557582 http://dx.doi.org/10.3390/ijms15022892

Ejemplares similares

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
por: Shimura, Satomi, et al.
Publicado: (2017)

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
por: Watashi, Koichi, et al.
Publicado: (2014)

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Curcumin inhibited hepatitis B viral entry through NTCP binding
por: Thongsri, Piyanoot, et al.
Publicado: (2021)

Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment
por: Li, Yan, et al.
Publicado: (2022)

Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications
por: Li, Wenhui, et al.
Publicado: (2016)

N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx
por: Murata, Takayuki, et al.
Publicado: (2023)

Structural insights into the HBV receptor and bile acid transporter NTCP
por: Park, Jae-Hyun, et al.
Publicado: (2022)

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus
por: Kitamura, Kouichi, et al.
Publicado: (2018)

Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
por: Donkers, Joanne M., et al.
Publicado: (2017)

Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes
por: Akahori, Yuichi, et al.
Publicado: (2020)

Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2
por: Suzuki, Ryosuke, et al.
Publicado: (2013)

Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression
por: Sun, Suofeng, et al.
Publicado: (2017)

Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection
por: Sakurai, Fuminori, et al.
Publicado: (2017)

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers
por: Kikuchi, Minami, et al.
Publicado: (2021)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide
por: Kaneko, Manabu, et al.
Publicado: (2018)

The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro
por: Gad, Sameh A., et al.
Publicado: (2022)

Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication
por: Iwamoto, Masashi, et al.
Publicado: (2017)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022)

Innovative HBV Animal Models Based on the Entry Receptor NTCP
por: Wettengel, Jochen M., et al.
Publicado: (2020)

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins
por: Miyakawa, Kei, et al.
Publicado: (2022)

Unlocking the secrets to human NTCP structure
por: Qi, Xiangbing, et al.
Publicado: (2022)

Many Keys Unlock the Doors for Virus Entry
por: Gallagher, Tom
Publicado: (2022)

NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population
por: Nyarko, Eric, et al.
Publicado: (2020)

Tyrosine 146 of the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

Encephalomyocarditis Virus Entry Unveiled
por: Cherry, Sara
Publicado: (2019)

Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus
por: Yamamoto, Satomi, et al.
Publicado: (2016)

An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes
por: Furutani, Yutaka, et al.
Publicado: (2019)

Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction
por: Tsukamoto, Yuta, et al.
Publicado: (2018)

Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection
por: Takemori, Toshitada, et al.
Publicado: (2022)

HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection
por: Zahoor, Muhammad Atif, et al.
Publicado: (2022)

Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection
por: Uchida, Takuro, et al.
Publicado: (2021)

Effect of S267F variant of NTCP on the patients with chronic hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2017)

Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor
por: Takeuchi, Fumihiko, et al.
Publicado: (2019)

Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide
por: Okuyama-Dobashi, Kaori, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eur1oruqppssh6dc9ov2lev4ru